Clinical trial
Effects of Methylphenidate Versus Sustained Release Methylphenidate on Cognitive…
NCT00418691 · M.D. Anderson Cancer Center, Other · Terminated
Key facts
| NCT number | NCT00418691 |
|---|---|
| Title | Effects of Methylphenidate Versus Sustained Release Methylphenidate on Cognitive Functioning |
| Official title | Assessing the Efficacy of Immediate Release Methylphenidate, Sustained Release Methylphenidate and Modafinil for Patients With Brain Tumors |
| Lead sponsor | M.D. Anderson Cancer Center, Other |
| Status | Terminated |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Brain Tumor |
| Intervention type | Drug |
| Interventions | IR Methylphenidate, Modafinil, SR Methylphenidate |
| Enrollment | 34 |
| Start date | Feb 1, 2004 |
| Primary completion | Nov 1, 2009 |
| Completion | Nov 1, 2009 |
| First posted | Jan 5, 2007 |
| Last update posted | Sep 23, 2020 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: